Immediate Impact

2 from Science/Nature 50 standout
Sub-graph 1 of 24

Citing Papers

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
2022 Standout
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
3 intermediate papers

Works of David Douglas being referenced

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle‐invasive transitional cell carcinoma of the bladder
2012
Fibroblast growth factor 17 is over‐expressed in human prostate cancer
2004

Author Peers

Author Last Decade Papers Cites
David Douglas 244 51 3 60 15 357
Aurélie Caillault 239 162 68 11 390
Cheung Wong 184 39 125 17 381
Susana Kofman 261 17 99 23 411
Tjinta Brinkhuizen 122 35 24 16 323
Monica Torello 181 34 52 14 368
Rachel Shukrun 312 27 67 18 383
K Yamanaka 102 61 46 17 309
Rebeca San Martin 186 26 52 13 330
P.M. Chou 190 65 22 17 319
Saskia M. Bergevoet 220 42 84 14 366

All Works

Loading papers...

Rankless by CCL
2026